Latest debt-to-equity ratio
Sunshine Biopharma Debt-to-equity ratio
Direct answer
Sunshine Biopharma's debt-to-equity ratio is 2.46%.
The verified market snapshot reports 2.46%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 25, 2026.
Get free Sunshine Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.46%
Explore related company data
View Sunshine Biopharma's market capitalizationView Sunshine Biopharma's price-to-book ratioView Sunshine Biopharma's return on equityView Sunshine Biopharma's 52-week price rangeView Sunshine Biopharma's revenue growthView Sunshine Biopharma's profit marginView all Sunshine Biopharma key metricsReturn to Sunshine Biopharma profile